These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15039100)

  • 1. LAAE-14, a new anti-inflammatory drug, increases the survival of Candida albicans-inoculated mice.
    Lucas R; Villamón E; Payá M; Alves M; del Olmo E; Gozalbo D; Gil ML
    FEMS Immunol Med Microbiol; 2004 Apr; 40(3):239-42. PubMed ID: 15039100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of leflunomide on gastrointestinal Candida albicans infection induced in naive and arthritic newborn mice.
    Dimitrova P; Ivanovska N
    Int Immunopharmacol; 2006 Nov; 6(11):1682-9. PubMed ID: 16979122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low dose of Concanavalin-A enhances innate immune response and prevents liver injury in mice infected with Candida albicans.
    Conchon-Costa I; Loyola W; Gaziri LC; Custódio LA; Felipe I
    FEMS Immunol Med Microbiol; 2007 Apr; 49(3):330-6. PubMed ID: 17284281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candida albicans strain-dependent virulence and Rim13p-mediated filamentation in experimental keratomycosis.
    Mitchell BM; Wu TG; Jackson BE; Wilhelmus KR
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):774-80. PubMed ID: 17251477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential cytokine production and Toll-like receptor signaling pathways by Candida albicans blastoconidia and hyphae.
    van der Graaf CA; Netea MG; Verschueren I; van der Meer JW; Kullberg BJ
    Infect Immun; 2005 Nov; 73(11):7458-64. PubMed ID: 16239547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of C3H/HE J mice from development of Candida albicans infection by oral administration of Juzen-taiho-to and its component, Ginseng radix: possible roles of macrophages in the host defense mechanisms.
    Akagawa G; Abe S; Tansho S; Uchida K; Yamaguchi H
    Immunopharmacol Immunotoxicol; 1996 Feb; 18(1):73-89. PubMed ID: 8683040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The importance of strain variation in virulence of Candida dubliniensis and Candida albicans: results of a blinded histopathological study of invasive candidiasis.
    Asmundsdóttir LR; Erlendsdóttir H; Agnarsson BA; Gottfredsson M
    Clin Microbiol Infect; 2009 Jun; 15(6):576-85. PubMed ID: 19604278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rutin has therapeutic effect on septic arthritis caused by Candida albicans.
    Han Y
    Int Immunopharmacol; 2009 Feb; 9(2):207-11. PubMed ID: 19041425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of salivary components that induce transition of hyphae to yeast in Candida albicans.
    Leito JT; Ligtenberg AJ; Nazmi K; Veerman EC
    FEMS Yeast Res; 2009 Oct; 9(7):1102-10. PubMed ID: 19799638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a serum-based antifungal susceptibility assay to predict the in vivo efficacy of novel echinocandin compounds.
    Maki K; Matsumoto S; Watabe E; Iguchi Y; Tomishima M; Ohki H; Yamada A; Ikeda F; Tawara S; Mutoh S
    Microbiol Immunol; 2008 Aug; 52(8):383-91. PubMed ID: 18667037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential regulation of the transcriptional repressor NRG1 accounts for altered host-cell interactions in Candida albicans and Candida dubliniensis.
    Moran GP; MacCallum DM; Spiering MJ; Coleman DC; Sullivan DJ
    Mol Microbiol; 2007 Nov; 66(4):915-29. PubMed ID: 17927699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of Candida albicans morphogenesis by tumor necrosis factor-alpha and potential for treatment of oral candidiasis.
    Ohta H; Tanimoto T; Taniai M; Taniguchi M; Ariyasu T; Arai S; Ohta T; Fukuda S
    In Vivo; 2007; 21(1):25-32. PubMed ID: 17354610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of diclofenac sodium in the dimorphic transition in Candida albicans.
    Ghalehnoo ZR; Rashki A; Najimi M; Dominguez A
    Microb Pathog; 2010; 48(3-4):110-5. PubMed ID: 20026399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of T-cell immunoregulation by ochnaflavone in therapeutic effect on fungal arthritis due to Candida albicans.
    Lee JH
    Arch Pharm Res; 2011 Jul; 34(7):1209-17. PubMed ID: 21811929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of anti-Candida activity of macrophages by a quorum-sensing molecule, farnesol, through induction of oxidative stress.
    Abe S; Tsunashima R; Iijima R; Yamada T; Maruyama N; Hisajima T; Abe Y; Oshima H; Yamazaki M
    Microbiol Immunol; 2009 Jun; 53(6):323-30. PubMed ID: 19493200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic use of liposomized tuftsin enhances the susceptibility of Candida albicans to fluconazole in leukopenic mice.
    Khan MA; Khan A; Owais M
    FEMS Immunol Med Microbiol; 2006 Feb; 46(1):63-9. PubMed ID: 16420598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptor 2 mediates prostaglandin E(2) production in murine peritoneal macrophages and splenocytes in response to Candida albicans.
    Villamón E; Roig P; Gil ML; Gozalbo D
    Res Microbiol; 2005; 156(1):115-8. PubMed ID: 15636756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of anti-Candida antibodies in mice with gut colonization of Candida albicans.
    Tansho S; Abe S; Ishibashi H; Mitsuya M; Wada K; Ikeda T; Suegara N; Koshio O; Ono Y; Yamaguchi H
    Mediators Inflamm; 2004 Jun; 13(3):189-93. PubMed ID: 15223610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Both viable and killed Candida albicans cells induce in vitro production of TNF-alpha and IFN-gamma in murine cells through a TLR2-dependent signalling.
    Murciano C; Yáñez A; Gil ML; Gozalbo D
    Eur Cytokine Netw; 2007 Mar; 18(1):38-43. PubMed ID: 17400537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo effectiveness of egg yolk antibody against Candida albicans (anti-CA IgY).
    Ibrahim el-SM; Rahman AK; Isoda R; Umeda K; Van Sa N; Kodama Y
    Vaccine; 2008 Apr; 26(17):2073-80. PubMed ID: 18375022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.